BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32021349)

  • 1. Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus - A Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Pingali U; Nutalapati C; Illendulla VS
    Diabetes Metab Syndr Obes; 2020; 13():31-42. PubMed ID: 32021349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Omega-3 Fatty Acid Alone and in Combination with Proprietary Chromium Complex on Endothelial Function in Subjects with Metabolic Syndrome: A Randomized, Double-Blind, Parallel-Group Clinical Study.
    Pingali U; Nutalapati C; Gundagani S
    Evid Based Complement Alternat Med; 2021; 2021():2972610. PubMed ID: 34257675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
    Usharani P; Merugu PL; Nutalapati C
    BMC Complement Altern Med; 2019 May; 19(1):97. PubMed ID: 31060549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.
    Mansoori A; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Nasli-Esfahani E; Shidfar F; Alvandi E; Toupchian O; Koohdani F
    J Clin Lipidol; 2015; 9(6):770-777. PubMed ID: 26687697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
    Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.
    Paulo MC; Andrade AM; Andrade ML; Morais MG; Kiely M; Parra D; Martinéz JA; Thorsdottir I; Bandarra NM
    Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):664-70. PubMed ID: 18420395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.
    Usharani P; Fatima N; Muralidhar N
    Diabetes Metab Syndr Obes; 2013; 6():275-84. PubMed ID: 23935377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study.
    Pingali U; Sukumaran D; Nutalapati C
    Phytother Res; 2020 Dec; 34(12):3226-3235. PubMed ID: 32618037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.
    Mori TA; Woodman RJ; Burke V; Puddey IB; Croft KD; Beilin LJ
    Free Radic Biol Med; 2003 Oct; 35(7):772-81. PubMed ID: 14583341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Effect of an Aqueous Extract of
    Pingali U; Ali MA; Gundagani S; Nutalapati C
    Diabetes Metab Syndr Obes; 2020; 13():4401-4412. PubMed ID: 33244247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
    Schwellenbach LJ; Olson KL; McConnell KJ; Stolcpart RS; Nash JD; Merenich JA;
    J Am Coll Nutr; 2006 Dec; 25(6):480-5. PubMed ID: 17229894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
    Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
    Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE
    Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.